Healthy male
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Healthy males from 20 to 64 years of age
Exclusion criteria
Exclusion criteria: (1) Subjects routinely taking medicine or health food that may affect the evaluation of the study (2) Subjects who has under treatment or a history of serious disease(e.g., diabetes, liver disease, kidney disease, or heart disease) (3) Subjects having possibilities for emerging allergy related to the current study (4) Subjects who are under medication or having a history of serious diseases for which medication was required (5) Subjects taking warfarin (product name: Warfarin, Warin, Alephrine, Warfarin K etc) for cerebral infarction or heart disease etc., those who need to take warfarin during the research period (6) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study (7) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (8) Subjects who are judged as unsuitable for the current study based on the results of clinical and physical preliminary examination (9) Subjects judged as unsuitable for the study by the investigator for other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Area under the curve of plasma glucosamine levels | — |
Secondary
| Measure | Time frame |
|---|---|
| maximum plasma glucosamine levels, glucosamine concentration at each time point | — |
Countries
Japan
Contacts
TTC Co., Ltd Clinical Research Planning Department